Worldwide, tuberculosis (TB) remains the most frequent and important infectious disease causing morbidity and death. One-third of the world's population is infected with Mycobacterium tuberculosis (Mtb), the etiologic agent of TB. In this context, TB is in the top three, with malaria and HIV being the leading causes of death from a single infectious agent, and about two million deaths are attributable to TB annually. The bacterial enzyme MurA catalyzes the transfer of enolpyruvate from phosphoenolpyruvate (PEP) to uridine diphospho-N-acetylglucosamine (UNAG), which is the first committed step of bacterial cell wall biosynthesis. In this work, 3D structural model of Mtb-MurA enzyme has been developed, for the first time, by homology modeling and molecular dynamics simulation techniques. The model provided clear insight in its structure features, i.e. substrate binding pocket, and common docking site. Multiple sequence alignment and 3D structure model provided the putative substrate binding pocket of Mtb-MurA with respect to E.coli MurA. This analysis was helpful in identifying the binding sites and molecular function of the MurA homologue. Molecular docking study was performed on this 3D structural model, using different classes of inhibitors like fosfomycin, cyclic disulfide analog RWJ-3981, pyrazolopyrimidine analog RWJ-110192, purine analog RWJ-140998, 5-sulfonoxy-anthranilic acid derivatives T6361, T6362 and the results showed that the 5-sulfonoxyanthranilic acid derivatives is showed best interaction compared with other inhibitor, taking in to this we also design a new efficient analogs of T6361 and T6362 which are showed even better interaction with Mtb-MurA than the parental5-sulfonoxy-anthranilic acid derivatives. Further the comparative molecular electrostatic potential and cavity depth analysis of Mtb-MurA suggested several important differences in its substrate and inhibitor binding pocket. Such differences could be exploited in the future for designing of a more specific inhibitor for Mtb-MurA enzyme 2
short peptide branches, Lipid II is translocated to the outer surface of the plasma membrane, where penicillin-binding proteins use it for the cell wall assembly. Inhibition of these synthetic enzymes show an impact on peptidoglycan biosynthesis, which results in disruption of the structural integrity in the cell wall and in turn leads to cell lysis. The absence of a homologue in eukaryotic cells makes MurA an attractive target for small molecule inhibitors with the potential to have broad antibacterial activity. Despite the availability of both recombinant MurA and a straightforward assay method to identify inhibitors of the enzyme since 1992 [11] , fosfomycin has remained the only MurA inhibitor on record in the literature and also three new inhibitors (RWJ-3981, RWJ-110192, RWJ-140998) are identified for MurA enzyme in E .coli [12] . Even so, mycobacterium strains are resisted against these inhibitors (fosfomycin, RWJ-3981, RWJ-110192 and RWJ-140998) due to lack of functional serine residues in Mtb-MurA enzyme [13] [14] [15] . Recently, two new inhibitors (T6361, T6362) have been identified for MurA enzyme. From the experimental studies, these inhibitors (T6361, T6362) have been found to show best inhibition rate compared to other MurA inhibitors (fosfomycin, RWJ-3981, RWJ-110192 and RWJ-140998) [16] . To the best of our knowledge, little attention has been paid to the theoretical study on the three-dimensional modeling of Mtb-MurA to make a deeper understanding of Mtb-MurA molecular level; an attempt is made in this paper to build up a three-dimensional model of Mtb-MurA by the homology module of Modeller9v1. The structural features and the structural stability of this homology model and docking studies with substrate and inhibitors (fosfomycin, RWJ-3981, RWJ-110192, RWJ-140998 T6361 and T6362) are exploited for future possibility of rational drug design.
Methods 3D model building
The protein sequence of Mtb-MurA was obtained by simple key word web-search at NCBI database. Sequence homology search of Mtb-MurA can be carried out using FASTA [17] or blast-P [18] . Three crystal structures 1A2N, 1UAE and 1NAW exhibiting sequence homology with MtbMurA were down loaded from PDB. All the MurA sequences were aligned with Mtb-MurA sequence using a multiple sequence alignment tool Clustal-X [19] . The homology model of MurA protein was built by using crystal structure coordinate sets having PDB ID 1A2N, 1UAE from E. coli [20, 21] , and 1NAW from Enterobacter cloacae [22] based on sequence alignment with Mtb-MurA sequence as a target. The initial model of Mtb-MurA was built by using homology-modeling methods and the Modeller9v1. The optimization procedure is a variable target function method that applies the conjugate gradient's algorithm to all non hydrogen atoms at various positions [23] . Many runs of model building were carried out to obtain the most reasonable homology model of Mtb-MurA. For the modeling of variable loops as the new loop conformation around different sub sites (in the crucial part of the model), a preliminary structural investigation on the graphics screen was performed to scrutinize the reliability of the alignment and to find out if adjustment in the alignment was necessary, further manual realignment will be carried out. The homology-modeling phase was followed by the model evaluation phase. Secondary structure prediction of Mtb-MurA model has been carried out through PDBSUM online server, which provides the complete data about the helices, beta sheets, turns present in the structure [24] . A MotifScan server is used for identification of motifs or domains present in Mtb-MurA model ( http://scansite.mit.edu). The structural stability of the models was tested by MD simulations. Using a Gromacs force field [25] that describes the inter atomic interactions, it was possible to solve the Newton motion equations for the investigated system and to calculate how each atom's coordinated to vary as a function of time.
Molecular Dynamics
For molecular dynamics calculation was carried out with Gromacs 3.2.1, using Gromacs Force field. Built MtbMurA model was immersed in a solvent octahedral box of 17413 SPC water molecules (15 A o thick layer of water, with box size of 90A X 90A X 90A). Na+ counter ions were added to neutralize the systems (5 Na+ ions were added). A twin-rage cutoff was used for log-range interactions: 1.5 nm for electrostatic interactions and 1.2 nm for Vander Walls interactions. The energy of the system was minimized to about 1000 cycles, using the steepest descent algorithm followed by heating to 300 K. All MD runs used a time step of 1 ns along with the LINCS routine to constrain bond lengths [26] and SETTLE to constrain water geometric [27] . The simulation was completed on 64 bit Athalon Intel 2.8 GHz AMD CPU. Molecular graphics were created using the programs Pymol 0.99 (http://pymol.sourceforge.net).
Evaluation of Mtb-MurA model
The programs PROCHECK [28] , ProSA-web [29] and What IF [30] were used in this step. Dissatisfying results in the validation tests provoked changes in the model. Thus, modified models were minimized as before and submitted to a new validation. But the result was the same, which led to new changes in the last models. This iterative process, of constant validation and generation of models, was carried out until the best model was obtained. The three-dimensional structure that introduced the most satisfactory result in the evaluation tests constituted the final model of Mtb-MurA.
Active site analysis:
The binding pockets of Mtb-MurA were identified using Multiple sequence alignment and CASTP (Computed Atlas of Surface Topography of Proteins) [31] ; a program for identifying and characterizing protein active sites, binding sites and functional residues located on protein surface and void buried in the interior of proteins by measuring concave surface regions on three-dimensional structures of proteins. It also measures the area and volume of a pocket or void by solvent accesble surface model and by molecular surface model. It also comes handy in the study of surface features and functional regions of proteins.
Electrostatic potential
The electrostatic potential (EP) around the template and the modeled molecular systems was calculated by solving nonlinear Poisson-Boltzmann equation using finite difference method [32] as implemented in the DS DelPhi module. The potential was calculated on grid points per side (70, 70, 70) and the grid fill by solute' parameter was set to 80%. The dielectric constant of the solvent and the solute was set to 80.0 and 2.0, respectively. An ionic exclusion radius of 2.0 A ˚, a solvent radius of 1.4 A ˚ and a solvent ionic strength of 0.145 M were applied. CHARMM charges and radii were used for this calculation. The solvent exposure was calculated using the Connolly algorithm with a probe of 1.4 A˚ radius [33] .
Ligand preparation and docking analysis:
Substrate UDP-N-Acetyl-Glucosamine (CID: 643981) and inhibitors fosfomycin (CID:8687), RWJ-3981, RWJ-110192, RWJ-140998 5-sulfonoxy-anthranilic acid derivatives T6361, T6362 and the analogs of T6361, T6362 were designed and partial charges were added using PRODRG server [34] . An initial population was generated based on the seed structure and the parent molecules (T6361, T6362) were copied into the mating pool. Thus, a new population was generated by performing structural manipulations to the molecules (T6361, T6362) in the mating pool. The generated molecules were analyzed using the PROCESS module in LigBuilder [35] . A set of 100 molecules meeting the chemical criteria set up in the parameter file in PROCESS module was filtered and then converted into viewable Mol2 formatted files. The compounds were then tested for Lipinski's Rule of Five using the Molinspiration server. (http://www.molinspiration.com/). The screened best of 5 structures (T6361&2-I,  T6361&2-II,  T6361&2-III,  T6361&2 -IV, T6361&2-V), atomic partial charges were added using PRODRG server. The docking studies were performed with the program Autodock 4.0 [36] . The Autodock graphical interface AutoDockTools [37, 38] was used to keep polar hydrogen and add partial charges for protein Mtb-MurA using the Kollman United charges. Atomic solvation parameters and fragmental volumes were assigned using the ADDSOL subroutine. The grid maps were calculated using the auxiliary program Autogrid4.0. Grid maps of 70 x 70 x70 points centered on the binding site of the ligand with 0.375 A˚ spacing were calculated for each of the atom types found on the adducts. Lamarckian genetic algorithm (LGA) was selected for ligands conformational searching [39] . Default parameters were used, except for the number of energy evaluations and docking runs, which were set to 2,000,000 and 200, respectively. The resulting docked conformations were clustered into families of similar conformations, with the root mean square deviation (RMSD) clustering tolerance of 0.5A ˚. As a rule, the lowest docking-energy conformations were included in the largest cluster. Flexible torsion in the ligands was assigned with Autotors, an auxiliary module of AutoDockTools.
Results

Sequence Analysis and 3D model building
The Mtb-MurA amino acid sequence was obtained from NCBI, which showed 418 amino acids with gi no: NP_215831. The sequence homology search was done for Mtb-MurA using blast-P with PDB selected as database at NCBI, which showed indication of three PDB ID: 1A2N, 1UAE and 1NAW which showed highest homology based on e-value. The multiple sequence alignment of MtbMurA with sequences of 1A2N, 1UAE and 1NAW was done with Clustal-X, which showed that two inserted residues were found one at 1 st position with Met and another at 74 th position with Arg and further two residues were deleted at position 152 and 418 (Fig. 1) . The 3-D model of Mtb-MurA was built by Modeller9v1 using three crystal structure coordinates as template structures (1A2N, 1UAE and 1NAW). The Modeller9v1 program uses the spatial constrains determined from the crystal structures, to build a 3-D model of target protein with unknown tertiary structures. 100 runs were carried out to obtain the most reasonable model and built model was optimized using energy command in Modeller.
Molecular dynamics:
To obtain a more reasonable structure, we performed nanosecond timescale molecular dynamics simulations for the structure Mtb-MurA. The plots of potential energy fluctuation ( Fig. 2A) and protein backbone RMSD (Fig.  2B ) from simulations showed that the structure was equilibrated after 1000ps of simulation. Thus, we selected the last 4ns simulation results to obtain an average structure using the g_rmsf program of Gromacs. The root mean square fluctuation (RMSF) of the protein was measured during the last 10ns of the 20ns MD simulation, as the structure at that time already several nanoseconds in an equilibrium state. Fig. 2C revealed active site residues belong with the less flexible part of the protein with minimum fluctuation in time. The RMSF of Asp305 and Arg397 describes these residues as the most rigid part of the protein and thus these amino acids should play the key role for substrate specificity. The catalytic residue Asn24 shows a little less rigidity, which can be interpreted that they must be able to orient themselves to the O-glycosidic bond after substrate binding.
Mtb-MurA model evaluation
Structural accuracy of Mtb-MurA model was done through PROCHECK, which revealed that all stereochemical and geometrical parameters have been implemented in the built model of Mtb-MurA. The Ramachandran plot constructed for Mtb-MurA model showed that all amino acids (100%) were present in the most favored (Fig. 3A) , generously and additional allowed regions and that no single amino acid in disallowed regions was found, which confirms that the model built for Mtb-MurA using Modeller9v1 was highly reliable. The main chain properties of Mtb-MurA model had shown to contain no considerable bad contact. The side chain parameters of Mtb-MurA model showed that the Gfactor values 1.0 are also inside the permitted range, which determines the normality of the degree of protein properties. Further it revealed that the X 1 -gouche minus standard deviation -1.80, trans standard deviation -1.9, gouche plus standard deviation -2.0, X 1 pooled standard deviation -2.1 and X 2 trans deviation -2.0 were in good agreement with the expected values and the bond length and hydrogen bond also did not deviate significantly from standard values. The protein structure analysis program ProSA-web was also used to evaluate the quality of the models. ProSA-web analyses the energy distribution in protein structure as a function of sequence position to identify a structure as native like or fault. Fig.3B . shows the energy profiles of Mtb-MurA model and crystal structure 1A2N. The over all quality or Z score of the 1A2N and Mtb-MurA reveals similar correlation with the energy pattern among X-ray and NMR structures. The Z-score measures the deviation of the total energy of the structure with respect to an energy distribution derived from random conformations. The ProsA-web analysis of MtbMurA model shows the Z-score of -9.86, which is within the range characteristic for native proteins indicating the good quality of the built model. The packing quality of each residues of Model Mtb-MurA also reaches the criteria of WHATIF, because there is no score lowers than -5.0 in the built Mtb-MurA structure and also built model showings best results compared with crystal structure 1A2N as shown in (Fig.3C) . Hence with all these evaluations the built Mtb-MurA model has been characterized as one of the best structure even suitable for further analysis like dynamics and docking.
Secondary structure analysis of Mtb-MurA model
The secondary structure characterization of Mtb-MurA model has been done through the PDBSUM online server which provides information of different helices, stands, turns and loops etc., The secondary structural elements of Mtb-MurA model (Fig.4A) showed 18 helices, 6 beta sheets, 4 beta-alpha-beta motifs, 5 beta hairpins, 2 beta bulges, 24 stands, 33 helix-helix interactions, 23 beta-turns and 1 gamma-turn, six beta sheet with mixed type confirmations. The most significant structural difference of Mtb-MurA model with crystal structure 1A2N, is at the loop region of 113-121 which is near to sheet-7 and in whole structure two residues are inserted in middle of the chain and two are deleted at the end of the chain.
Active site analysis of Mtb-MurA model
Once the final model was built and validated, the possible binding sites of Mtb-MurA were searched using CASTP server. Forty eight possible binding sites of Mtb-MurA were obtained from the server. These pockets were compared with the active site the templates 1A2N, 1UAE and 1NAW, which were found to have degrees of identity above 95% for the active site in all the cases. When the high identity template 1A2N1UAE and 1NAW, was submitted to the Multiple sequence alingment it provided the residues at active site of structure, and taking that into account comparison of Mtb-MurA model also showed more similar identities at active site amino acids region with Asn24, Asp305, Arg397 (Fig. 4B ).
Domain analysis of Mtb-MurA model
The analysis of Mtb-MurA model clearly indicated that it was composed of two active functional domains (http://hits.isb-sib.ch/cgi-bin.pfscan). The domain one of Mtb-MurA model (yellow color in Fig. 5 ) was similar to EPSP-synathase (3-Phosphoshikimate 1-carboxyvinyltransferase) from 7 to 406, which catalyzes the sixth step in the biosynthesis from chorismate of the aromatic amino acids [40] . The domain two of Mtb-MurA model (blue color in Fig. 5 was similar to a bacterial transferase hexapeptide from 131-148 (present with in the first domain) has acyltransferase activity [41] .
Electrostatic potential Analysis:
The EP is an electrical effect of the electrons and nuclei of a molecule in its vicinity [42] . Protein electrostatic potential is an indicator of electrostatic properties that are evolutionarily selected by a protein to perform a specific function [43] . The electrostatic potential of proteins caused by side chains of polar and charged residues plays a role in protein folding and stability, enzyme catalysis and specific protein-protein or protein-ligand recognition. The computer graphics representation of the molecular surface electrostatic potential is a powerful tool for studying intermolecular specificity because it eases the simultaneous search for both steric and electrostatic complementarities in protein-ligand interactions. The calculated electrostatic is potential mapped on to the solvent accessible surface of the models and the template is presented for comparison in Fig. 6 .
Docking analysis:
Inhibitors Fosfomycin, RWJ-3981, RWJ-110192, RWJ-140998 5-sulfonoxy-anthranilic acid derivatives T6361, T6362 was prepared for docking by adding addition of partial charges using PRODRG server [33] . Using the pharmacophore model, 50 out of the initial 100 molecules satisfying the minimum chemical criteria were identified for further analysis. The 50 compounds were then grouped in 21 different clusters using structural similarity. A molecule from each cluster was chosen based on binding affinity to integrase. Five of the twenty-one molecules satisfied the Lipinski's rule of five with zero violations. A useful parameter for predicting drug transport properties is TPSA (Topological Molecular polar surface area) and it is determined for these molecules. A topological parameter is number of rotatable bonds, and it describes the molecular flexibility of these compounds. This parameter was calculated for the fourteen molecules that satisfy the 'rule-of-5', and it was found that all the molecules have rotatable bonds in the range of 2-6 ( Table 2 ). The 100 docking conformations for substrate and inhibitors (RWJ-3981, RWJ-110192, RWJ-140998 5-sulfonoxy-anthranilic acid derivatives T6361, T6362 and the analogs of T6361, T6362) were divided into groups according to a 1.0 Å RMSD criterion by using the Clustering module in ADT. The substrate showed the best interaction with predicted active site amino acid (Arg24, Asp305, Asn397) and for inhibitors except fosfomycin and RWJ-3981 which has the two energyclose (higher than 0.01 kcal/mol) conformations, all the other inhibitors, mainly take good binding conformation with (negative amino acid region in surface of Mtb-MurA) predicted amino acids (Arg24, Asp305, Asn397). Besides RMSD clustering, AutoDock also uses binding free energy evaluation to find the best binding mode. Energy items energy, and electrostatic energy), internal energy, and torsion energy. The first two items build up docking energy; the first and the third item compose the binding energy. During all these interactions, the hydrogen bond between ligand and enzyme is the most important, because in most cases it can decide the binding strength and the location of ligand, whereas the hydrophobic interaction of certain groups can affect the inhibition specialty to a large extent. The energy information is listed in Table 1 , and the interaction modes of inhibitors (RWJ-3981, RWJ-110192, RWJ-140998 5-sulfonoxy-anthranilic acid derivatives T6361, T6362 and the analogs of T6361, T6362) are shown in Fig. 6A, B Docking analysis revealed that these inhibitors can enter the substrate-binding region of the active site. In the arrangements with the lowest docked energies, inhibitors were sandwiched between the active site residues Asn24, Asp305 and Arg397. Hydroxyl groups of 5-sylfonoxy-anthranilic acid derivatives were orienting towards the amino groups of the catalytic amino acid residues Asn24 and Arg397. The results clearly showed that 5-sulfonoxy-anthranilic acid analogs T6361&2-I more accurately interact with Mtb-MurA than the other inhibitors (Fig. 6H) .
Discussion:
In spite of the availability of effective chemotherapy like isoniazid, rifampicin drugs and Bacille-CalmetteñGuerin (BCG) vaccine, tuberculosis remains a leading infectious killer world-wide. Many factors such as, a human immunodeficiency virus (HIV) co-infection, drug resistance, lack of patient compliance with chemotherapy, delay in diagnosis, variable efficacy of BCG vaccine and drugs, various other factors contribute to the rate of mortality due to tuberculosis, for this there is need to development of a new anti tuberculosis drug. The search for new antibacterial agents directed towards novel targets has become highly imperative. The machinery for peptidoglycan biosynthesis is a rich source of crucial targets for antibacterial chemotherapy. The cytoplasmic steps of the biosynthesis of peptidoglycan precursor, catalyses by a MtbMurA enzyme, is an excellent candidate for drug development. A 3D structural model of Mtb-MurA was constructed and refined using systematic implementation of various computational techniques, including sequence analysis, homology modeling and the stability of the model was implemented through Gromacs software package. The reliability assessment of the built model of Mtb-MurA was carried out with PROCHECK, ProsA-Web and WHATIF showed that the model was reliable and of good quality which is suitable for further structural and functional analysis at molecular level. Mtb-MurA model showing both potential energy and RMSD values was found to be stable after 1ns simulation time and the RMSF of Mtb-MurA showed that all active site residues in the rigid region play an important role in substrate binding. Ramachandran plot analysis showed 100% residues with in most favored, generous and additional allowed regions and 0% in a disallowed region indicating the high quality model. AutoDock4.0 evidence shows lowest binding energies of substrate UDP-N-Acetyl-Glucosamine and inhibitors fosfomycin, 5-sulfonoxy-anthranilic acid derivatives T6361, T6362 with Mtb-MurA enzyme, which revel in the functional important regions of Mtb-MurA enzyme. An analog of parental (T6361, T6362) compounds showed better inhibition than that of parental and existing inhibitors. Hence the studies conducted systematically in the present work, i.e., the computational design of 3-D structures of Mtb-MurA enzymes, dynamics and docking studies are expected to provide highly useful information towards rational design of new tuberculosis drugs through experimental research design for further formulations as per pharmaceutical norms.
